Stockscreener 앱 받기
1.13
40.72%
0.327
시간 외 거래:
1.15
0.02
+1.77%
전일 마감가:
$0.803
열려 있는:
$0.833
하루 거래량:
7.35M
Relative Volume:
7.23
시가총액:
$5.68M
수익:
-
순이익/손실:
$-28.70M
주가수익비율:
-0.0228
EPS:
-49.5275
순현금흐름:
$-3.22M
1주 성능:
+61.61%
1개월 성능:
-20.98%
6개월 성능:
-92.53%
1년 성능:
-95.59%
1일 변동 폭
$0.833
$1.29
1주일 범위
$0.5483
$1.29
52주 변동 폭
$0.5483
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
명칭
Aspire Biopharma Holdings Inc
전화
561-704-8527
주소
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
1.13 | 4.03M | 0 | -28.70M | -3.22M | -49.53 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Aspire Biopharma Holdings Inc 주식(ASBP)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - Bitget
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Livingston Daily
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer
ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget
Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Record Searchlight
Aspire subsidiary names John Choe as western sales director - Investing.com
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire
He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - The Hutchinson News
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Black Hills Pioneer
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with N - GuruFocus
Aspire Biopharma Holdings Inc (ASBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):